Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Alexander, J S ^a   Patton, W F ^c   Christman, B W ^b   Cuiper, L L ^b   Haselton, F R ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Endothelial barrier

Indexed keywords

LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE A2;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

EID: 33750887288     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.1.h115     Document Type: Article

References (33)

1. Alexander, J. S., O. Blaschuk, and F. R. Haselton. An N-cadherin-like protein contributes to the maintenance of solute barrier in cultured bovine aortic endothelial cells. J. Cell. Physiol. 156: 610-618, 1993.
2. Alexander, J. S., H. B. Hechtman, and D. Shepro. Phalloidin enhances endothelial barrier function and reduces inflammatory permeability in vitro. Microvasc. Res. 35: 308-315, 1988.
3. Amano, M., K. Chihara, K. Kimura, Y. Kukata, N. Nakamura, Y. Matsura, and K. Kaibuchi. Formation of actin stress finers and focal adhesions enhanced by rho-kinase. Science 275: 1308-1311, 1997.
4. Bjerve, K., L. Daae, and J. Bremen The selective loss of lysophospholipids in some commonly used lipid-extraction procedures. Anal. Biochem. 58: 238-245, 1974.
5. Eichholtz, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680, 1993.
6. Gerrard, J. M., and P. Robinson. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochima. Biophysica. Acta 1001: 282-285, 1989.
7. Haselton, F. R., and J. S. Alexander. Platelets and a platelet-released factor enhance endothelial barrier. Am. J. Physiol. 263 (Lung Cell Molec. Physiol. 7): L670-L678, 1992.
8. Haselton, F. R., J. S. Alexander, and S. N. Mueller. Adenosine decreases permeability of endothelial monolayers. J. Appl. Physiol. 74: 1581-1590, 1993.
9. Haselton, F. R., J. S. Alexander, S. N. Mueller, R. Howell, and A. P. Fishman. Modulators of endothelial permeability: a mechanistic approach. In: Endothelial Biology in Health and Disease, edited by N. Simionescu and M. Simionescu. New York: Plenum, 1992, p. 103-126.
10. Haselton, F. R., S. N. Mueller, R. E. Howell, E. M. Levine, and A. P. Fishman. Chromatographic demonstration of reversible changes in endothelial permeability. J. Appl. Physiol. 67: 2032-2048, 1989.
11. Holmsen, H., and H. J. Weiss. Secretable storage pools in platelets. Annu. Rev. Med. 30: 119-134, 1979.
12. Horiguchi, Y., T. Senda, N. Sugimoto, J. Katahira, and M. Matsuda. Bordatella bronchisepta dermonecrotizing toxin stimulates assembly of actin stress fibers, and focal adhesions by modifying the small GTP-binding protein rho. J. Cell Sci. 108: 3243-3251, 1995.
13. Jalink, K., W. H. Moolenaar, and B. Van Duijn. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae. Proc. Natl. Acad. Sci. USA 90: 1857-1861, 1993.
14. Kimura, K., I. Masaali, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamon, J. Feng, T. Nakano, K. Okawa, A. Iwamatsu, and K. Kaibuchi. Regulation of myosin phosphatase by rho, and rho-associated kinase (rho-kinase). Science 273: 245-248, 1996.
15. Knapp, H. R., I. A. G. Reilly, P. Alessandri, and G. A. Fitzgerald. In vivo indexes of platelet, and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 314: 937-942, 1986.
16. Ma, Y. H., D. R. Harder, J. E. Clark, and R. J. Roman. Effects of 12-HETE on isolated dog renal arcuate arteries. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H451-H456, 1991.
17. Moolenaar, W. H., K. Jalink, and E. J. van Corven. Lysophosphatidic acid: a bioactive phospholipid with growth factor-like properties. Rev. Physiol. Biochem. Pharmacol. 119: 48-65, 1992.
18. Nobes, C. D., and A. Hall. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23: 456-459, 1995.
19. Nusrat, A., M. Giry, J. R. Turner, S. P. Colgan, C. A. Parkos, D. Carnes, E. Lemichez, P. Boquet, and J. L. Madara. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc. Natl. Acad. Sci. USA 92: 10629-10633, 1995.
20. Paty, P. S., P. F. Sherman, J. M. Shepard, A. B. Malik, and J. E. Kaplan. Role of adenosine in platelet mediated reduction in pulmonary vascular permeability. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H771-H777, 1992.
21. 3 formation in rat-1 fibroblasts. Biochem. J. 280: 609-615, 1991.
22. Prescott, S. M., T. M. McIntyre, and G. A. Zimmerman. The role of platelet-activating factor in endothelial cells. Thromb. Haemost. 64: 99-103, 1990.
23. Ridley, A. J., and A. Hall. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399, 1992.
24. Seufferlein, T., and E. Rozengurt. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact. Requirement of p21rho in the signaling pathway. J. Biol. Chem. 270: 24343-24351, 1995.
25. Shasby, D. M., S. S. Shasby, J. M. Sullivan, and M. J. Peach. The role of the endothelial cytoskeleton in the control of endothelial permeability. Circ. Res. 51: 657-661, 1982.
26. Shepard, J. M., D. G. Moon, P. F. Sherman, L. K. Weston, P. J. Del Vecchio, F. L. Minnear, and A. B. Malik. Platelets decrease albumin permeability of pulmonary artery endothelial cell monolayers. Microvasc. Res. 37: 256-266, 1989.
27. Tigyi, G., and R. Miledi. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267: 21360-21367, 1992.
28. Tokumura, A., K. Fukuzawa, and H. Tsukatani. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids 13: 572-574, 1978.
29. Tokumura, A., K. Harada, K. Fukuzawa, and H. Tsukatani. Involvement of lysophospholipid D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta 875: 31-38, 1986.
30. Van Corven, E. J., A. van Rijswijk, K. Jalink, R. L. van der Bend, W. J. van Blitterswijk, and W. H. Moolenaar. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J. 281: 163-169, 1992.
31. Van der Bend, R. L., J. Brunner, K. Jalink, E. J. van Corven, W. H. Moolenaar, and W. J. van Blitterswijk. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J. 11: 2495-2501, 1992.
32. Van der Bend, R. L., J. de Widt, E. J. van Corven, W. H. Moolenaar, and W. J. van Blitterswijk. The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Biochem. J. 285: 235-240, 1992.
33. Yamada, Y., T. Furumuchi, H. Furui, T. Yokoi, K. Yamauchi, M. Yokota, H. Hayashi, and H. Saito. Roles of calcium, cyclic nucleotides and protein kinase C in regulation of endothelial permeability. Arteriosclerosis 10: 410-420, 1990.